Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc.verified

BLPH

Price:

$0.036

Market Cap:

$440.37K

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension asso...[Read more]

Industry

Biotechnology

IPO Date

2015-02-13

Stock Exchange

NASDAQ

Ticker

BLPH

The ROE as of November 2024 (TTM) for Bellerophon Therapeutics, Inc. (BLPH) is -151.06%

According to Bellerophon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -151.06%. This represents a change of 47.49% compared to the average of -102.42% of the last 4 quarters.

Bellerophon Therapeutics, Inc. (BLPH) Historical ROE (quarterly & annually)

How has BLPH ROE performed in the past?

The mean historical ROE of Bellerophon Therapeutics, Inc. over the last ten years is 73.57%. The current -151.06% ROE has changed -305.33% with respect to the historical average. Over the past ten years (40 quarters), BLPH's ROE was at its highest in in the December 2017 quarter at 931.34%. The ROE was at its lowest in in the March 2017 quarter at -2392.88%.

Quarterly (TTM)
Annual

Average

73.57%

Median

-107.25%

Minimum

-782.60%

Maximum

2.11%

Bellerophon Therapeutics, Inc. (BLPH) ROE by Quarter and Year

Discovering the peaks and valleys of Bellerophon Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 852.86%

Maximum Annual ROE = 2.11%

Minimum Annual Increase = -1696.62%

Minimum Annual ROE = -782.60%

Quarterly (TTM)
Annual
YearROEChange
2022-782.60%852.86%
2021-82.13%27.04%
2020-64.65%-82.50%
2019-369.45%-606.26%
201872.98%-96.55%
20172.11%-1696.62%
2016-132.36%-13.57%
2015-153.15%-41.13%
2014-260.16%-166.04%
2013393.96%-5.27%

Bellerophon Therapeutics, Inc. (BLPH) Average ROE

How has BLPH ROE performed in the past?

The current ROE of Bellerophon Therapeutics, Inc. (BLPH) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-309.79%

5-year avg

-245.17%

10-year avg

73.57%

Bellerophon Therapeutics, Inc. (BLPH) ROE vs. Peers

How is BLPH’s ROE compared to its peers?

Bellerophon Therapeutics, Inc.’s ROE is less than Bio-Path Holdings, Inc. (0%), greater than Catalyst Biosciences, Inc. (-2842.40%), less than Diffusion Pharmaceuticals Inc. (1.20%), greater than Capricor Therapeutics, Inc. (-55460.19%), greater than NextCure, Inc. (-220.26%), greater than Zura Bio Limited (-57.63%), greater than Altamira Therapeutics Ltd. (-35.45%), less than Immix Biopharma, Inc. (783.37%), greater than Enveric Biosciences, Inc. (-86.48%), greater than Palisade Bio, Inc. (-234.16%), greater than null (-124.86%),

Build a custom stock screener for Bellerophon Therapeutics, Inc. (BLPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellerophon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellerophon Therapeutics, Inc. (BLPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellerophon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Bellerophon Therapeutics, Inc.'s ROE?

How is the ROE calculated for Bellerophon Therapeutics, Inc. (BLPH)?

What is the highest ROE for Bellerophon Therapeutics, Inc. (BLPH)?

What is the 3-year average ROE for Bellerophon Therapeutics, Inc. (BLPH)?

What is the 5-year average ROE for Bellerophon Therapeutics, Inc. (BLPH)?

How does the current ROE for Bellerophon Therapeutics, Inc. (BLPH) compare to its historical average?